Translation and Validation of the Thai Version of the Nasal Obstruction Symptom Evaluation (NOSE) Scale

Completed

• Conditions: nasal septal deviation with clinical chronic nasal airway obstruction lasting at least 3 months; Nasal airway obstruction; NOSE Questionnaire; Deviated nasal septum; Validation

• Registration Number: TCTR20220706006
• Lead Sponsor: /A

Brief Summary

The Thai-NOSE was found to be adequate for all tested psychometric properties with high internal consistency Cronbachs alpha 0.942, and to discriminate accurately between patients and healthy controls. The inter-item and item-total correlations indicated a related construct among all items. A high level of reproducibility of the questionnaire was obtained in the test-retest procedure for each item gramma 0.898. The initial test and retest scores indicated adequate reproducibility.

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-01-31
• Study Start: 2022-07-06
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

. The first group consisted of patients who were able to read and speak Thai, were aged at least 18 years old, who had nasal septal deviation with clinical chronic nasal airway obstruction lasting at least 3 months, and who had persistent symptoms after 4 weeks of medication (tropical nasal steroid, decongestants, oral antihistamine). The diagnosis was performed using rigid endoscopy or CT scans.

Exclusion Criteria

sinonasal malignancy, previous or ongoing radiation therapy of the head and neck, previous septoplasty, rhinoplasty or turbinoplasty, a history or clinical evidence of chronic sinusitis, nasal septal perforation, craniofacial syndrome, nasal trauma or fracture in the past 3 months, nasal valve collapse, adenoid hypertrophy, sarcoidosis, Wegener granulomatosis, uncontrolled asthma, or pregnancy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Validity (construct) 14 days after initial test Inter-item and each item-total score were calculted and reported with Spearmans rho and p-value,Validity (discriminant) 14 days after initial test Total scores of each item between study patients and control group were calculted and reported with the independent t test and p-value,Internal Consistency 14 days after initial test Total scores between study patients and control group were calculted and reported with Cronbachs alpha coefficients,Test-Retest Reliability 14 days after initial test Scores from the initial test and retest of both groups were calculted and reported with Goodman-Kruskal gamma coefficient, paired t tests and p-value

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A